The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma

DOI: 10.1080/2162402X.2018.1486356

Keywords: Multiple myeloma, IKZF1, IKZF3, T cells, immunomodulatory drugs, immune, biomarker trials

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text